Siddha medicine Bala karappan kudineer(internal) and Karappan thailam(external) for Bala karappan (Atopic dermatitis) in children

PHASE II NON RANDOMIZED CLINICAL STUDY ON BALA KARAPPAN(ATOPIC DERMATITIS) WITH THE EVALUATION OF SIDDHA TRIAL DRUG BALA KARAPPAN KUDINEER(INTERNAL) AND KARAPPAN THAILAM(EXTERNAL) IN CHILDREN

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/07/034772

Enrollment

Registered

2021-07-12

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L209- Atopic dermatitis, unspecified

Interventions

Intervention1: Bala karappan kudineer (internal) Karappan thailam (external): 30ml of decoction bd for 21 days 5ml bd external application for 21 days Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: Itching Erythema Papules Vesicles Oozing Crusting Scaling Lichenification

Exclusion criteria

Exclusion criteria: Psoriasis Scabies Photo dermatitis Ichthyosis vulgaris Pityriasis alba

Design outcomes

Primary

Measure	Time frame
Reduction in EASI Score Reduction in Clinical symptoms Photo evidence before and after treatmentTimepoint: Reduction in EASI Score Reduction in Clinical symptoms Photo evidence before and after treatment	—

Secondary

Measure	Time frame
Comparing Safety parameters before and after treatmentTimepoint: 21 days	—

Countries

India

Contacts

Public ContactDr K K SHARMILADEVI

Governnment siddha medical college

drvranimd@yahoo.com6369113461

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026